BiomécaRichter: Concordance of Pelvic Organ Mobility Measurements Between the Finite Element Model and the Dynamic Pelvic Floor MRI in Patients Undergoing a Sacrospinofixation Surgery

Sponsor
Centre Hospitalier Universitaire de Besancon (Other)
Overall Status
Unknown status
CT.gov ID
NCT04551859
Collaborator
University Hospital, Lille (Other)
41
1
13

Study Details

Study Description

Brief Summary

The primary objective of this study is to demonstrate the feasibility of using a Finite Element model of pelvic organs by evaluating the concordance of pelvic organ mobility measurements performed by this mechanical model compared to the observations on the post-operative pelvic MRI in patients undergoing a sacrospinofixation surgery

Condition or Disease Intervention/Treatment Phase
  • Other: Dynamic Pelvic Floor MRI
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
41 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Concordance of Pelvic Organ Mobility Measurements Between the Finite Element Model and the Dynamic Pelvic Floor MRI in Patients Undergoing a Sacrospinous Ligament Fixation Surgery
Anticipated Study Start Date :
Oct 1, 2020
Anticipated Primary Completion Date :
Oct 1, 2021
Anticipated Study Completion Date :
Nov 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Other: Sacrospinofixation

After accepting the surgeon's proposal to perform a sacrospinofixation to treat the pelvic organ prolapse, participation in this study will be proposed to the patient. It will not change the management or the course of the surgery

Other: Dynamic Pelvic Floor MRI
6 months after surgery, a Dynamic Pelvic Floor MRI is performed

Outcome Measures

Primary Outcome Measures

  1. Concordance of mobility measurements of points C, Ba and Bp between the FE model and the dynamic MRI after SSF [6 months after surgery]

    Concordance of mobility measurements of the 3 points C, Ba, Bp during the defecation sequence, between the Finite Elements (FE) model and the dynamic pelvic floor MRI after sacrospinous ligament fixation (SSF)

Secondary Outcome Measures

  1. Concordance of mobility measurements of points Aa and Ap between the FE model and the dynamic MRI after SSF [6 months after surgery]

    Concordance of mobility measurements of points Aa and Ap during the defecation sequence, between the Finite Elements (FE) model and the dynamic pelvic floor MRI after sacrospinous ligament fixation SSF)

  2. Comparison of the pelvic organ mobility before and after surgery [6 months after surgery]

    Comparison of the mobility of the different points of the POP-Q classification (C, Ba, Bp, Aa, Ap) before and after surgery

  3. Elasticity study of the vaginal tissue (Lille) [after surgery (day 0)]

    Elasticity study of the vaginal tissue removed during surgery (for patients operated in Lille only)

  4. Concordance of mobility measurements between FE model enhanced by the vaginal tissue analysis and the dynamic MRI after SSF [6 months after surgery]

    Concordance of mobility measurements of the POP-Q points (C, Ba, Bp, Aa, Ba) during the defecation sequence, between the Finite Elements (FE) model enhanced by the analysis of the vaginal tissue sampling and the dynamic pelvic floor MRI after sacrospinous ligament fixation (SSF)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women aged 18 to 80

  • With at least a grade II apical prolapse according to the POP-Q classification

  • Treated with a sacrospinous ligament fixation (SSF) by the vaginal route

Exclusion Criteria:
  • History of abdominal, pelvic, vaginal or vulvar surgery except hysterectomy

  • Association of another POP or urinary incontinence surgery (subvesical plication, levator myorrhaphy, plication of anterior rectal wall, perineorrhaphy ...)

  • MRI contraindication

  • Legal incapacity or limited legal capacity

  • Subject unlikely to cooperate with the study

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Besancon
  • University Hospital, Lille

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Centre Hospitalier Universitaire de Besancon
ClinicalTrials.gov Identifier:
NCT04551859
Other Study ID Numbers:
  • 2020/510
First Posted:
Sep 16, 2020
Last Update Posted:
Sep 16, 2020
Last Verified:
Aug 1, 2020
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Universitaire de Besancon
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 16, 2020